Quantcast

Latest Prostate cancer Stories

2014-04-23 23:10:18

According to a new Korean study, a new method of diagnosing bladder cancer could “augment or replace” current approaches. Raleigh, NC (PRWEB) April 23, 2014 Cancer researchers in Korea say they have developed a simpler and less invasive way to diagnose bladder cancer from a urine sample. Details of the new study have just been posted on the Cancer Monthly website. Click here to learn more. Scientists with the Natural Product Research Institute at Seoul National University have...

2014-04-23 23:04:55

GIA announces the release of a comprehensive global report on Brachytherapy markets. Global market for Brachytherapy Devices is projected to reach US$411 million by 2020, driven by rising cancer cases, aging population, and growing need for more effective therapeutics. San Jose, California (PRWEB) April 23, 2014 Follow us on LinkedIn - Cancer has emerged as one of the most critical health issues worldwide. Rising incidence of cancer and growing medical awareness continues to increase the...

2014-04-23 23:04:09

New research report “Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis)” worked out by Kelly Scientific Publications is now available at MarketPublishers.com. London, UK (PRWEB) April 23, 2014 To date, more than 32 million people worldwide are living with cancer. The most frequently occurred types of cancer include breast,...

2014-04-23 16:31:29

First treatment approved for patients with rare blood disorder HORSHAM, Pa., April 23, 2014 /PRNewswire/ -- Janssen Biotech, Inc. ["Janssen"] today announced the U.S. Food and Drug Administration (FDA) has approved SYLVANT(TM) (siltuximab) for the treatment of patients with multicentric Castleman's disease (MCD) who are human immunodeficiency virus (HIV) negative and human herpesvirus-8 (HHV-8) negative. SYLVANT was not studied in patients with MCD who are HIV positive or HHV-8...

2014-04-23 16:29:46

MARINA DEL REY, Calif., April 23, 2014 /PRNewswire/ -- Join Prostate Oncology Specialists for an educational talk about PROVENGE - a treatment to stimulate the immune system for advanced prostate cancer. Prostate cancer specialist, Dr. Jeffrey Turner, presents and reviews key topics: Why PROVENGE might be right for me? How do I know the PROVENGE treatment is working?How is PROVENGE different from hormone or chemotherapy?Does PROVENGE affect my PSA?How does PROVENGE boost my immune...

2014-04-23 12:29:08

WORCESTER, Mass. and TORONTO, April 23, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that two abstracts in respect of results of the on-going Phase II study of a novel cancer vaccine designed to prevent relapse in patients who have had breast cancer will be presented at this year's American Society of Clinical Oncology (ASCO) Annual Meeting to be held in Chicago from May 30 to June 3, 2014. The ASCO Annual Meeting is the...

2014-04-23 08:31:00

Third Phase 3 Trial of Custirsen to Receive FDA Fast Track Designation BOTHELL, Wash. and VANCOUVER, British Columbia, April 23, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of custirsen when administered in combination with cabazitaxel/prednisone for the treatment of men with metastatic castrate-resistant prostate cancer (CRPC) following...

2014-04-22 12:31:49

LONDON, April 22, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: MediPoint: Biopsy Devices - EU Analysis and Market Forecastshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/medipoint_biopsy_devices_eu_analysis_market_forecasts.html MediPoint: Biopsy Devices - EU Analysis and Market Forecasts SummaryCancer is the uncontrolled growth of abnormal cells in the body. It can affect numerous organs and tissues of the body. When a patient is suspected...

2014-04-22 08:33:31

Company to Report On Science And Progress Of DCVax-Direct Trial At World's Largest Cancer Conference BETHESDA, Md., April 22, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that ASCO (the American Society for Clinical Oncology) has announced in its Annual Meeting program that the Company will present its DCVax-Direct clinical trial and technology...

2014-04-22 08:33:21

Expanded Reimbursement in Canada and Inclusion in Leading German Physician Guidelines Increase Genomic Health's Impact in Key International Markets REDWOOD CITY, Calif., April 22, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced two important international milestones including additional reimbursement in Canada and the inclusion of the Oncotype DX(®) breast cancer test in major German clinical guidelines. In Canada, the BC Cancer Agency in British Columbia...


Word of the Day
sough
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'
Related